Latest / Bloomberg Intelligence / Trump Aims to Cut US Drug Costs by Pegging to Prices Abroad
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news, and Android auto with
- 0:09Speaker 1: the Bloomberg Business App. Listen on demand wherever you get
- 0:12Speaker 1: your podcasts, or watch us live on YouTube.
- 0:15Speaker 2: Alex Stealier alongside plaus we need. This is Bloomberg Intelligence Radio.
- 0:18Speaker 2: We got to cover with the top news and business,
- 0:20Speaker 2: economics and finance through our lens of our Bloomberg Intelligence folks.
- 0:23Speaker 2: They cover two thousand companies and one hundred and thirty
- 0:25Speaker 2: industries all around the world. And thank goodness we have
- 0:27Speaker 2: them because we get a lot of news today, particularly
- 0:30Speaker 2: out of the drug makers from the White House. So
- 0:32Speaker 2: shares of pharmaceutical companies largely trading higher today. As President
- 0:36Speaker 2: Donald Trump's executive order was aimed at cutting US prescription
- 0:39Speaker 2: drug prices, it was sort of like the less bad news.
- 0:42Speaker 2: It was better than feared. One area though, will definitely
- 0:46Speaker 2: be a pharmacy benefit manager. Sam Fazzelli's Boomberg Intelligence director
- 0:50Speaker 2: of Research for Global Industries and senior pharmaceutical analyst, Sam,
- 0:55Speaker 2: can you just walk me through why do we hear
- 0:58Speaker 2: in the US pay more for drug pricing and should
- 1:01Speaker 2: that be reduced?
- 1:03Speaker 3: Yeah? So, Alex, the thing in the US is that
- 1:06Speaker 3: it's a price that's set by negotiation between farmer companies
- 1:12Speaker 3: and insurers, pharmacy benefit managers and payers. It is not
- 1:17Speaker 3: dictated by the government, at least it wasn't until recently,
- 1:20Speaker 3: whereas in Europe and many other countries you have a
- 1:23Speaker 3: single payer and that's the government and they play hardball
- 1:26Speaker 3: so they can get lower prices because that's the way
- 1:30Speaker 3: they operate, and they had. There are many situations where
- 1:33Speaker 3: in the UK the National Institute for Clinical Accident refuses
- 1:37Speaker 3: to believe or accept that a drug has got is
- 1:40Speaker 3: value added, so it's not even offered even at the
- 1:43Speaker 3: negotiated lower price. So that's the issue here, which means
- 1:47Speaker 3: that as soon as innovation happens is out in the market.
- 1:50Speaker 3: In the US, the day that a product is approved,
- 1:52Speaker 3: they can get on and sell it. Over in Europe
- 1:55Speaker 3: it could take a year two years for a drug
- 1:56Speaker 3: to come through, and maybe with this new execut order,
- 2:00Speaker 3: sometimes the companies will go where I'd rather not launch
- 2:03Speaker 3: in Europe.
- 2:05Speaker 4: So is it realistic to expect that drug prices in
- 2:09Speaker 4: the US will come down? Could come down?
- 2:13Speaker 3: The thing is, Paul, if I'm having a tough time
- 2:16Speaker 3: to balance this out. If the intention is for to
- 2:19Speaker 3: get the rest of the world to pay more, which
- 2:22Speaker 3: of course helps the farmer companies. Then I don't see
- 2:25Speaker 3: how that helps the US drug prices come down, right.
- 2:30Speaker 3: If they aren't able to increase prices in Europe, then
- 2:35Speaker 3: the government in the US is saying, well, you should
- 2:38Speaker 3: give us the same prices to giving elsewhere. Then innovation disappears,
- 2:42Speaker 3: because at the end of the day, if you cut
- 2:43Speaker 3: your revenue by half, you won't have and you spend
- 2:47Speaker 3: fifteen percent of that on R and D yes what
- 2:50Speaker 3: your RN defaults simple maths, So how this plays out
- 2:54Speaker 3: would be quite interesting to see. And of course we
- 2:56Speaker 3: have to also remember that there isn't a price in Europe,
- 2:59Speaker 3: so we just check the price. So we go v
- 3:01Speaker 3: in the UK at the effective dose two hundred and
- 3:03Speaker 3: thirty dollars, okay. In the US leader Novo sales it
- 3:08Speaker 3: for four hundred and ninety nine dollars to the director consumer. Okay,
- 3:11Speaker 3: it's about twice as much.
- 3:13Speaker 1: Okay.
- 3:14Speaker 3: So let's say in Europe it goes up to three
- 3:16Speaker 3: hundred during the UK, and how does that change with
- 3:19Speaker 3: the US number? And we don't even know whether the
- 3:23Speaker 3: company actually gives that price, because then there's a little
- 3:26Speaker 3: small print. We have been doing a commerce with the
- 3:29Speaker 3: NHS dot Are commercial deal. So what is the price?
- 3:32Speaker 3: How is the US government going to find that price
- 3:34Speaker 3: unless they incorporated into the trade agreements that they're doing,
- 3:37Speaker 3: which is what should be happening here.
- 3:40Speaker 2: So going for So what about the PBMs, So that
- 3:44Speaker 2: was singled out the pharmacy benefit managers as were the
- 3:47Speaker 2: middleman between insurers and the government and then drug makers,
- 3:50Speaker 2: et cetera. What role do they really have and are
- 3:54Speaker 2: they the ones most at risk?
- 3:58Speaker 3: I would say they are the ones most at risk.
- 4:00Speaker 3: I would say they should have always been the ones
- 4:02Speaker 3: most at risk because I don't understand the reason they
- 4:07Speaker 3: exist in the middle. I mean, that's the I can
- 4:09Speaker 3: show you a chart of how the US payment system works,
- 4:12Speaker 3: and it varies by insurance. You can you can go
- 4:15Speaker 3: from one job to another and the cost of your
- 4:17Speaker 3: drug goes up, right because you have a different insurance,
- 4:19Speaker 3: but from one state to another. So it's it's that
- 4:22Speaker 3: just really isn't is untenable? And it's nice to see
- 4:25Speaker 3: that the government, the administration is not talking about making
- 4:29Speaker 3: it easier to sell directly to consumers. So let me
- 4:31Speaker 3: give you an example. We have data on the terminal
- 4:34Speaker 3: that gives you an ability to calculate what a drug
- 4:37Speaker 3: revenue should have been in the past quarter volume times price. Right,
- 4:42Speaker 3: then you go and see what they actually reported. Sometimes
- 4:45Speaker 3: for Insulince, for instance, is eighty percent lower eighty percent?
- 4:50Speaker 3: Now the PBM say, I know, we passed that on
- 4:52Speaker 3: back to the to medical party. Why do you even
- 4:55Speaker 3: take it? Why do we need to pay an administrator
- 4:57Speaker 3: in the middle here?
- 4:59Speaker 4: That's great, soci What are your companies within your food
- 5:02Speaker 4: chain there in a big farmer. What are they saying,
- 5:05Speaker 4: Because this issue is new, We've been plaining about high
- 5:07Speaker 4: drug prices forever. What are they saying as to what
- 5:10Speaker 4: is likely to really happen.
- 5:13Speaker 3: They're not saying very much, Paul, you know, and in
- 5:15Speaker 3: this center circumstances, the best thing to do is to
- 5:17Speaker 3: keep your head down and see how things work out.
- 5:20Speaker 3: And of course today it's only just come out. So
- 5:23Speaker 3: I think they all to a t say the PBMs
- 5:26Speaker 3: are a problem, we need to get rid of it.
- 5:28Speaker 3: That so let's say that, But that's not today, That's
- 5:30Speaker 3: been going on for ten years. They also say Europe
- 5:34Speaker 3: should pay more, But they also say that when you
- 5:36Speaker 3: do the net price calculation in many instances. I actually
- 5:39Speaker 3: send you a code from Pascalsorio, the Astrisenica CEO, saying
- 5:44Speaker 3: that actually, in many cases the prices end up being
- 5:46Speaker 3: about the same, maybe a little bit different. So all
- 5:48Speaker 3: of that needs to be taken into account, and we
- 5:50Speaker 3: need to decide if they're going to push Europe higher
- 5:54Speaker 3: to pay more. Is the US also happy to move
- 5:57Speaker 3: some of the R and D to Europe? Maybe that's
- 5:58Speaker 3: something that the governments will ask for. Fine, we'll pay more,
- 6:02Speaker 3: but bring some of your R and D here, bring
- 6:03Speaker 3: more manufacturing here, same arguments.
- 6:06Speaker 2: So twenty seconds, the drugstocks are higher. Does this make
- 6:10Speaker 2: sense to you?
- 6:12Speaker 3: Yeah, Well, as you said, you got it right at
- 6:14Speaker 3: the beginning, Alex that this is not as bad as
- 6:17Speaker 3: people expected. And also I think we're in a world
- 6:20Speaker 3: where sometimes the president uses his power to really push
- 6:25Speaker 3: people into a into action, and then when he gets
- 6:28Speaker 3: what he wants, the action isn't as bad as sir.
- 6:30Speaker 2: All right, Sam, thanks a lot, Sam Fazelli, Bloomberg Intelligence.
- 6:33Speaker 2: We really appreciate you.
- 6:35Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us live
- 6:39Speaker 1: weekdays at ten am Eastern on Apple, Cocklay and Android
- 6:42Speaker 1: auto with the Bloomberg Business App, listen on demand wherever
- 6:46Speaker 1: you get your podcasts, or watch us live on YouTube.
- 6:50Speaker 2: All right, let's get some of the logistics here on
- 6:51Speaker 2: the policy side. Nathan Dean, Bloomberg Intelligence Senior policy analyst,
- 6:55Speaker 2: joins us. Now, so a couple of things to dissect. Obviously,
- 6:57Speaker 2: one is the executive order for Big Farman drugp pricing.
- 7:00Speaker 2: The others, of course US and China slashing tariffs. Here's
- 7:04Speaker 2: what I don't really understand. If we're going to go
- 7:05Speaker 2: back to tariffs that were roughly where they were before
- 7:08Speaker 2: the one hundred and forty five percent and one hundred
- 7:09Speaker 2: and twenty five percent on the respective countries, why are
- 7:12Speaker 2: we getting the sort of celebratory tone in the market.
- 7:16Speaker 5: Well, I think it's just because of the idea of
- 7:18Speaker 5: this pause. You know that the worst case scenario is
- 7:21Speaker 5: maybe not the worst case scenario. But you know, I
- 7:23Speaker 5: go back to what Treasury Secretary Scott Besson said this
- 7:26Speaker 5: morning in his interview with Jonathan Farrow. You know, and
- 7:28Speaker 5: I'm paraphrasing here, he said, Look, you know the one
- 7:30Speaker 5: hundred and forty five percent was because of China's retaliatory nature.
- 7:34Speaker 5: You know, if you go back to April second and
- 7:36Speaker 5: look at the liberation day of that thirty four percent.
- 7:38Speaker 5: It's a little bit more in line today with.
- 7:40Speaker 4: That thirty percent.
- 7:41Speaker 5: So I think the market is going to wake up
- 7:43Speaker 5: in the next day or so and realize that tariffs
- 7:45Speaker 5: are going to remain elevated. Yes, it's not going to
- 7:48Speaker 5: be as much as one hundred and forty five percent,
- 7:49Speaker 5: and that's a good thing. And maybe it opens up
- 7:52Speaker 5: the boats so that they can start coming into the
- 7:53Speaker 5: West coast of the United States and we begin to,
- 7:55Speaker 5: you know, alleviate this idea of you know, shelves being
- 7:59Speaker 5: empty and so forth. That but elevated tariffs are still
- 8:01Speaker 5: going to be here, and that's going to be the norm.
- 8:03Speaker 5: We're really working towards this kiddy scenario where it's like
- 8:06Speaker 5: a ten percent baseline tariff, maybe a little bit higher
- 8:08Speaker 5: for other countries like China, with special exemptions, maybe for automobile, automobiles,
- 8:13Speaker 5: pharmaceutical tech, you name it.
- 8:15Speaker 4: Hey, Nathan, to what extent died politics player role here,
- 8:18Speaker 4: folks on the hill, maybe Republicans saying to this White House, hey,
- 8:22Speaker 4: we got some elections coming up, and if we're talking
- 8:24Speaker 4: about these super high tariffs that could be a problem
- 8:26Speaker 4: for US.
- 8:27Speaker 5: Yeah, I think there was probably more politics here than
- 8:30Speaker 5: the White House was probably letting on. And I think
- 8:32Speaker 5: it's not so much the elections, but more so of
- 8:34Speaker 5: those Fourth of July barbecues, because you know, if you
- 8:37Speaker 5: think about it, and if you believe the idea that
- 8:39Speaker 5: you know, these a lot of these ships in the
- 8:41Speaker 5: coming into the West Coast and the United States are
- 8:43Speaker 5: down thirty to forty percent. These are these ships that
- 8:45Speaker 5: are bringing over items for the Christmas retail season. And
- 8:49Speaker 5: if you begin to see the combination of you know,
- 8:51Speaker 5: President Trump's comments on well maybe American children don't need
- 8:55Speaker 5: two dolls or thirty dollars, they get two dolls with
- 8:58Speaker 5: some empty store shelves, and with the idea that maybe
- 9:00Speaker 5: that we're going to get to a situation where small
- 9:03Speaker 5: businesses are really harmed from this. I think this was
- 9:06Speaker 5: sort of the White House's way of saying, look, you know,
- 9:08Speaker 5: we need to also try and save some face here.
- 9:10Speaker 5: You know, I didn't think they were going to go
- 9:11Speaker 5: down to thirty percent, you know, I think they around
- 9:13Speaker 5: sixty eighty percent is where you would have asked me
- 9:15Speaker 5: on Friday. I would have said, but you know they're
- 9:17Speaker 5: going to thirty percent. It does give the market a
- 9:19Speaker 5: lot of breathing room. Yes, we have lots of negotiations
- 9:22Speaker 5: that have to take place over the next ninety days,
- 9:24Speaker 5: but it's something the market can actually work with in
- 9:26Speaker 5: terms of clarity purposes.
- 9:28Speaker 2: I also wonder if there's breathing room now in terms
- 9:30Speaker 2: of dealing with a tax bill and focusing on deregulation,
- 9:34Speaker 2: what's the timing of both of those things there?
- 9:36Speaker 5: Well, So for the tax bill, this tariff announcement actually
- 9:39Speaker 5: hurts it a little bit from the standpoint that the
- 9:41Speaker 5: House Republicans were hoping to use two trillion dollars worth
- 9:44Speaker 5: of teriff revenue to help pay for this bill, which
- 9:47Speaker 5: is north of five trillion dollars. And you know, if
- 9:49Speaker 5: you come out and say, look, we're going to go
- 9:51Speaker 5: back to a ten percent baseline tariff for everybody at least,
- 9:54Speaker 5: what the situation is turning out to be, you're not
- 9:56Speaker 5: going to get anywhere close to that two trillion dollars.
- 9:59Speaker 5: So now the question is how you're going to pay
- 10:01Speaker 5: for it. Now, there's going to be some markups this
- 10:02Speaker 5: week House Energy and Commerce, House Ways and Means Committee.
- 10:05Speaker 5: By this time tomorrow you'll know exactly where the House
- 10:09Speaker 5: efforts are in terms of gutting things like the IRA
- 10:11Speaker 5: or changing the tax provisions of this country. But what
- 10:15Speaker 5: we're telling our clients is just remember the House is
- 10:18Speaker 5: throwing the kitchen sync in with this bill. They're throwing
- 10:20Speaker 5: in things that we don't think will even pass the
- 10:22Speaker 5: Senate parliamentarian and wouldn't even get under the what they
- 10:25Speaker 5: call the bird Rule, wouldn't even fly through that. So
- 10:27Speaker 5: look for everything to be thrown in and then things
- 10:30Speaker 5: to be scaled back. The biggest question though, is how
- 10:32Speaker 5: you're going to pay for it, And I don't think
- 10:34Speaker 5: anybody on Capitol Hill, on the Republican side, knows how
- 10:37Speaker 5: they're going to pay for it at this point. And
- 10:38Speaker 5: as a result, there is a possibility this may not
- 10:41Speaker 5: be permanent. They may be pulling it back and saying,
- 10:43Speaker 5: you know, maybe it's only worth four to six years
- 10:45Speaker 5: worth of tax extensions.
- 10:47Speaker 4: What are the dates that we need to pay attention
- 10:50Speaker 4: to it, because quite frankly, I am not paying attention.
- 10:52Speaker 4: I am overwhelmed. But you tell me the data I
- 10:54Speaker 4: need to pay attention here from what we're going to
- 10:56Speaker 4: hear from Congress.
- 10:57Speaker 5: So for the next two weeks. They're going to see
- 10:59Speaker 5: this debate in the so lots of headline risks, but
- 11:01Speaker 5: again it's just the headline risks. Ultimately, we think a
- 11:04Speaker 5: House vote will probably come at the end of this month,
- 11:06Speaker 5: or probably more likely in June. That's when the Senate's
- 11:09Speaker 5: going to get it. The Senate's going to say thank.
- 11:11Speaker 4: You very much.
- 11:11Speaker 5: They're going to essentially throw it out, and then they're
- 11:13Speaker 5: going to say, look, we will take you and do
- 11:14Speaker 5: whatever we want and send it back to you. We
- 11:17Speaker 5: think that's going to happen around the fourth of July
- 11:18Speaker 5: time frame. This is also under the assumption that the
- 11:21Speaker 5: debt ceiling remains in this bill, because if the Treasury
- 11:24Speaker 5: Secretary Scott Besson said the x state for that debt
- 11:26Speaker 5: ceiling is in August, Congress needs to wrap this up
- 11:29Speaker 5: before then. So we're thinking ultimate passage in that mid
- 11:32Speaker 5: to late July timeframe. If the debt ceiling provision is
- 11:35Speaker 5: script out, if there's nowhere, if they aren't anywhere close to,
- 11:38Speaker 5: you know, coming to a deal, they'll have to do
- 11:40Speaker 5: the debt ceiling separately. And then the real deadline for
- 11:43Speaker 5: this is probably going to be the October November time frame.
- 11:46Speaker 2: In terms of then the market as we sort of
- 11:48Speaker 2: look ahead to that, what's going to be the next
- 11:50Speaker 2: catalyst within the first next week or week and a half.
- 11:52Speaker 4: What are you looking for?
- 11:54Speaker 5: So I think it's going to really be the House
- 11:56Speaker 5: deficit Republicans. You know, this is Representative Chip Roy for example,
- 12:00Speaker 5: he just tweeted out about twenty minutes ago that he
- 12:02Speaker 5: is not going to vote for a bill that he
- 12:04Speaker 5: in his words, would add twenty trillion dollars to the deficit. Now,
- 12:08Speaker 5: I'm not going to say that we think we'll go
- 12:10Speaker 5: that far, but you are going to see a lot
- 12:12Speaker 5: of statements from Republicans who are not happy with this legislation.
- 12:15Speaker 5: And it's just part of the negotiation. So look for this.
- 12:18Speaker 5: Towardo sort of seesaw moment of yes, we have a deal, No,
- 12:21Speaker 5: we don't have a deal. But I think for the
- 12:22Speaker 5: next two weeks you're going to see more negative headlines
- 12:25Speaker 5: than positives.
- 12:26Speaker 4: And then sometimes maybe around Memorial Day.
- 12:28Speaker 5: I think the Republicans will start to get a better
- 12:30Speaker 5: idea of what that plan is going to look like
- 12:32Speaker 5: in order to get House passage.
- 12:34Speaker 2: All right, great stuff. Really appreciate Nathan Nathan Dean Bloomberg
- 12:36Speaker 2: Intelligence senior policy analyst. Joining us there.
- 12:40Speaker 1: You're listening to the Bloomberg Intelligence Podcast. Catch us Live
- 12:44Speaker 1: weekdays at ten am Eastern on Apple, Coarcklay and Android
- 12:47Speaker 1: Auto with the Bloomberg Business App. Listen on demand wherever
- 12:50Speaker 1: you get your podcasts, or watch us live on YouTube.
- 12:54Speaker 4: Let's get right to our next guest, James Aboute. Joins
- 12:57Speaker 4: is managing director and chief investment officer of Course Center
- 13:00Speaker 4: Asset Management. James, we wake up this morning, it seems
- 13:05Speaker 4: like maybe the trade environments not that terrible, not that strict.
- 13:10Speaker 4: What do you make about it? And what do you
- 13:11Speaker 4: make of the markets move today?
- 13:14Speaker 6: Well, clearly, you know the announcement that the US is
- 13:17Speaker 6: going to cut tariffs on Chinese goods of thirty percent
- 13:20Speaker 6: from one hundred and forty five percent for ninety days,
- 13:24Speaker 6: and then China is going to cut tariffs in the
- 13:26Speaker 6: US because the ten percent from one hundred twenty five
- 13:29Speaker 6: is good news.
- 13:30Speaker 7: It's a it's a truce again. This is a ninety
- 13:33Speaker 7: day cooling off period, though, I'll have to see what develops,
- 13:36Speaker 7: you know, unfortunately, what we see with President Trump though,
- 13:39Speaker 7: as he continues to negotiate against himself in public. It's
- 13:43Speaker 7: a little like watching the same person playing twins, like
- 13:46Speaker 7: Michael B. Jordan on Sinners who played the actor or
- 13:49Speaker 7: the actor who played the Winkeelwash twins in the movie
- 13:52Speaker 7: The Social Network. It's like the same person negotiating against themselves.
- 13:56Speaker 7: So I think market's going to remain volerable, and it
- 14:00Speaker 7: might be a country's best interest to just stall on
- 14:03Speaker 7: reaching a trade agreement with the United States, given how
- 14:05Speaker 7: we seem to be able to negotiate against ourselves and
- 14:08Speaker 7: lowering barriers.
- 14:09Speaker 2: But to that point, does the market understand that there
- 14:13Speaker 2: is some kind of a trump put So is the
- 14:15Speaker 2: reaction function on the initial headline now going to just
- 14:19Speaker 2: be a little different.
- 14:21Speaker 7: It's possible, But you know, at the end of the day,
- 14:24Speaker 7: what we really need to see is the US convert
- 14:27Speaker 7: this current relationship. And China is the best example of
- 14:30Speaker 7: a significant trade deficit in return for capital inflows, namely
- 14:36Speaker 7: into our treasury market, with a trade deficit that somehow
- 14:39Speaker 7: equals you know, inbound fixed investment. I think there's a
- 14:43Speaker 7: lot of probability that we can accomplish that with the
- 14:45Speaker 7: EU in Japan, I'm not so sure we can accomplish
- 14:48Speaker 7: that with China.
- 14:50Speaker 4: All right, James as a chief investment officer and somebody
- 14:53Speaker 4: manages money other folks' money.
- 14:56Speaker 7: What do you do here?
- 14:57Speaker 4: How's your world changed in the last four or five months?
- 15:00Speaker 8: Here? Well?
- 15:03Speaker 6: Where of the belief that the risk of recession has
- 15:06Speaker 6: been reduced.
- 15:07Speaker 7: So clearly when you think about that, you know what
- 15:09Speaker 7: sector should investors be looking at? And we've been very
- 15:13Speaker 7: much pounding the table that US regional banks are poised
- 15:16Speaker 7: to benefit from number of tailwinds. One's a steepening yield curve,
- 15:21Speaker 7: better loan activity, some degree of acceleration in M and A,
- 15:25Speaker 7: and even amasing of a regulatory environment. So you know,
- 15:29Speaker 7: when you look at the regional banks after the recent
- 15:32Speaker 7: sell off that we had, with many trading at price
- 15:34Speaker 7: the tangible book multiples just above one, they have what
- 15:38Speaker 7: we believe to be the best asymmetrical opportunity in the market,
- 15:42Speaker 7: and see them as a prime beneficiary of increased US
- 15:46Speaker 7: on shoring and a movement of supply chains to domestic manufacturers.
- 15:50Speaker 7: So you know, for us, the source of funds that
- 15:52Speaker 7: people should be looking at are consumer stables. Giving the
- 15:56Speaker 7: recent disappointment and not really being very defensive at all,
- 15:59Speaker 7: and even the magnific since seven. We think the terrific
- 16:02Speaker 7: opportunity for you know, active management now is really quite unprecedented,
- 16:08Speaker 7: and this pivotal moment away from the magnificent seven away
- 16:11Speaker 7: as the year progresses, might be quite strong.
- 16:14Speaker 2: All right, James, really appreciate it. Thank you so much.
- 16:16Speaker 2: I don't end your position at all. Jams about day, Benagin,
- 16:19Speaker 2: Director and chief investment officer at a Center Asset Management.
- 16:24Speaker 1: You're listening to the Bloomberg Intelligence Podcast. Catch us live
- 16:28Speaker 1: weekdays at ten am Eastern on Apple Coarcklay and Android
- 16:31Speaker 1: Auto with the Bloomberg Business App. Listen on demand wherever
- 16:35Speaker 1: you get your podcasts, or watch us live on YouTube.
- 16:39Speaker 4: You know, So we've already got some agreements here. I
- 16:42Speaker 4: guess one hundred and forty five percent US levies almost
- 16:44Speaker 4: Chinese imports. That's going to come down to thirty percent,
- 16:46Speaker 4: one hundred and twenty five percent Chinese duties on US goods.
- 16:49Speaker 4: That will drop the ten percent for three months to
- 16:52Speaker 4: get the country's time to negotiate a broader agreement, so
- 16:55Speaker 4: maybe they can get something done and maybe a discussion
- 16:57Speaker 4: between the two leaders can accelerate that.
- 16:59Speaker 2: Yeah, and that raises the question of what do you
- 17:01Speaker 2: do with the markets?
- 17:02Speaker 3: Right?
- 17:02Speaker 2: So you look at the rally and you're like, oh,
- 17:03Speaker 2: you have lots of optimism, etc. But I wonder in
- 17:06Speaker 2: reality how much of that is actually funds. You've got
- 17:08Speaker 2: a couple of things going on right, Commodity trading advisors
- 17:11Speaker 2: so they're called CTAs. You have volatility controlled funds. You
- 17:14Speaker 2: have hedge funds where they sort of shift around based
- 17:17Speaker 2: on how much risk they're allowed to kind of carry,
- 17:19Speaker 2: based on what the markets actually do. So City says
- 17:22Speaker 2: that CTAs have flipped long on the S and P,
- 17:24Speaker 2: their max long on the Nest at one hundred and
- 17:26Speaker 2: now covering shorts in the Russell two thousand based on
- 17:30Speaker 2: moves this morning, and that if you see kind of
- 17:33Speaker 2: a change in the S and P, you're going to
- 17:34Speaker 2: have to add on to this, meaning that just because
- 17:37Speaker 2: you see a rally doesn't mean it's real extended fundamentals.
- 17:40Speaker 4: Yep, it's so fabulous.
- 17:41Speaker 3: Point.
- 17:41Speaker 4: That's good. I love Storic Kaiser from the folks over
- 17:44Speaker 4: at City with his notes are very clear and easy
- 17:47Speaker 4: to understand. I appreciate getting those notes. Let's go to
- 17:50Speaker 4: a pro here. Brent Standardge, President Consumer and Business banking
- 17:54Speaker 4: at Huntington Bank. Hey, bring, We've got it. Just tremendous
- 17:57Speaker 4: amounts of volatilty so far here in twenty twenty five.
- 18:00Speaker 4: When you go sit down with your corporate clients, how
- 18:04Speaker 4: is it reflected in their activity? Are they sitting on
- 18:06Speaker 4: their hands? Are they trying to move forward? What are
- 18:08Speaker 4: you hearing? Well?
- 18:10Speaker 8: Paul, First of all, thank you for having us on
- 18:12Speaker 8: the show. We are closely monitoring all the developments that
- 18:16Speaker 8: relate to the broader economy, and today's announcement is clearly
- 18:19Speaker 8: another data point. Our focus has been on our customers
- 18:23Speaker 8: and what we're hearing specifically from our customers is really
- 18:25Speaker 8: more of a wait and see. All of the events
- 18:28Speaker 8: of the last few months have introduced a higher level
- 18:31Speaker 8: of uncertainty and as a result, many of our customers
- 18:34Speaker 8: are waiting to see what will happen and delaying some
- 18:39Speaker 8: decisions to obtain more certainty.
- 18:42Speaker 2: So, based on that, what are the expansion plans for
- 18:46Speaker 2: Huntington Like you are you doubling down?
- 18:48Speaker 3: Here?
- 18:48Speaker 2: Are you staying? Are you holding pat Because a lot
- 18:50Speaker 2: of companies are just like, we're in a weight and
- 18:52Speaker 2: see mode. We're delaying, but we're not abandoning kind of projects.
- 18:55Speaker 2: How are you guys thinking.
- 18:56Speaker 8: About it, Well, we're continuing forward with our investment plans.
- 19:00Speaker 8: This is an important proof point for our organic growth story.
- 19:05Speaker 8: We're very bullish about our opportunity that exists in the Carolinas.
- 19:09Speaker 8: It's a fast growing, dynamic market. We already have thirty
- 19:11Speaker 8: thousand customers there. Our approach and culture have allowed us
- 19:15Speaker 8: to attract some really fantastic and talented individuals. And our
- 19:19Speaker 8: business model really resonates in the market, which is around
- 19:22Speaker 8: local and bringing highly qualified bankers with local relationships to
- 19:27Speaker 8: those customers, supported with national expertise. And so we believe
- 19:32Speaker 8: that in times like this, those customers and those relationships
- 19:36Speaker 8: are even more important, and so we're continuing forward with
- 19:39Speaker 8: our investment plans, not just in the Carolinas, but across
- 19:42Speaker 8: the country.
- 19:44Speaker 4: What are the areas that for your clients that you
- 19:47Speaker 4: find most attractive? What are the sectors that you guys
- 19:50Speaker 4: like right now as you approach your corporate clients.
- 19:53Speaker 8: Well, our business model is based on having relationships with
- 19:56Speaker 8: middle market, commercial and small business customers, and we do
- 20:01Speaker 8: that across a wide variety of different industries, and then
- 20:04Speaker 8: we support those local relationships with industry expertise, so we're
- 20:09Speaker 8: not focused in on a specific industry. We're more focused
- 20:13Speaker 8: on medium and small businesses and supporting their day to
- 20:18Speaker 8: day needs.
- 20:21Speaker 2: Talk to me about the concerns that your customers are
- 20:23Speaker 2: talking about and their needs and how that might have changed.
- 20:28Speaker 8: Well, going back to a previous comment, it has introduced uncertainty. Obviously,
- 20:34Speaker 8: not being aware of what a product will cost or
- 20:38Speaker 8: how the supply chain may be impacted causes businesses to
- 20:43Speaker 8: stop and consider. And we're seeing changes almost every day,
- 20:48Speaker 8: and businesses are figuring it out and they're talking to
- 20:51Speaker 8: their own suppliers, and that's clearly leads to uncertainty. So
- 20:56Speaker 8: as these decisions are made, as things become more clear,
- 21:00Speaker 8: we believe businesses will continue and resume any investment that's
- 21:07Speaker 8: been delayed.
- 21:08Speaker 4: So, you know, a lot of folks are concerned that
- 21:11Speaker 4: with tariffs, it's kind of the small, mid sized businesses
- 21:15Speaker 4: that might be impacted the most. The inability to take
- 21:17Speaker 4: costs increases and pass them through to customers on like
- 21:20Speaker 4: say Walmart or something. Is that what you're hearing from
- 21:23Speaker 4: your customers, Well, I don't think they know at this point.
- 21:27Speaker 8: Clearly, this is a time for us to be closer
- 21:30Speaker 8: to customers and be able to support them regardless of
- 21:34Speaker 8: the economic scenario.
- 21:35Speaker 4: And we believe that we're well.
- 21:37Speaker 8: Positioned to do this, but I don't think they know
- 21:39Speaker 8: at this point everyone or every business certainly is impacted
- 21:45Speaker 8: and supplies chains are impacted, and we want to be
- 21:48Speaker 8: there to support them as they make decisions day to day.
- 21:50Speaker 8: But at this point it's a little bit early to
- 21:52Speaker 8: know that there.
- 21:53Speaker 2: Was a lot of deposit competition for savings that seem
- 21:56Speaker 2: to then hit the pause button.
- 21:59Speaker 4: Where do you are we in deposit.
- 22:01Speaker 2: Beta and how do you stay competitive?
- 22:04Speaker 8: Well, we're very, very fortunate that we have a very
- 22:07Speaker 8: granular deposit base. In fact, if you look at the
- 22:11Speaker 8: percentage of deposits that we have their FDIC insured, it's
- 22:14Speaker 8: the highest in our peer group.
- 22:16Speaker 4: And that deposit base has been quite stable for us.
- 22:18Speaker 8: In fact, we've been able to grow it at a
- 22:20Speaker 8: period of time when others have not been successful. So
- 22:24Speaker 8: we're continuing to see that same trend. We've been very
- 22:28Speaker 8: successful at continuing to grow the deposit portfolio. Obviously, as
- 22:32Speaker 8: rates come down, interest expense and the cost of that
- 22:34Speaker 8: deposit book has come down, and we will continue to
- 22:38Speaker 8: monitor that closely, but it is the deposit environment has
- 22:44Speaker 8: been competitive for some period of time, and I would
- 22:46Speaker 8: say there hasn't been dramatic changes in the last number
- 22:50Speaker 8: of months.
- 22:52Speaker 4: All right, Brent, thank you so much. We appreciate A.
- 22:53Speaker 4: Bri Stanbridge. He is President Consumer and Business Banking at
- 22:58Speaker 4: Huntington Bank in Columbus, Ohio. That is the bank of
- 23:03Speaker 4: mister Matthew Miller. So how about that talk about if
- 23:07Speaker 4: Grangler depositor right there. So we'd like to speak to
- 23:11Speaker 4: some of these bankers at the mid market, but a
- 23:13Speaker 4: should get a sense of kind of how the corporate
- 23:16Speaker 4: and mid size and middle market companies you're behaving and
- 23:18Speaker 4: are they investing, how are they investing, So those bankers
- 23:21Speaker 4: give us a good view there.
- 23:22Speaker 1: This is the Bloomberg Intelligence podcast, available on Apple, Spotify,
- 23:27Speaker 1: and anywhere else you get your podcasts. Listen live each
- 23:31Speaker 1: weekday ten am to noon Eastern on Bloomberg dot Com,
- 23:35Speaker 1: the iHeartRadio app, tune In, and the Bloomberg Business app.
- 23:39Speaker 1: You can also watch us live every weekday on YouTube
- 23:42Speaker 1: and always on the Bloomberg terminal